Academic Journals Database
Disseminating quality controlled scientific knowledge

Synergistic Effect of Probiotics, Butyrate and l-Carnitine in Treatment of IBD

Author(s): Mahsa Moeinian | Seyedeh Farnaz Ghasemi-Niri | Shilan Mozaffari | Mohammad Abdollahi

Journal: Iranian Journal of Medical Hypotheses & Ideas
ISSN 1735-9104

Volume: 7;
Issue: 2;
Start page: 50;
Date: 2013;
Original page

Keywords: l-Carnitine | Inflammatory Bowel Disease | IκB Kinase | Butyrate | Probiotics | Oxidative Stress

Genetic, environmental factors, dysregulation of immune system, intestinal microbes and oxidative stress are the most important factors that play the role in the pathogenesis of inflammatory bowel disease (IBD). Current treatments do not always result in complete remission and usually accompanied with several adverse effects. Recent studies showed that nuclear factor-kappa B (NF-κB), tumor necrosis factor-α (TNF-α) and oxidative stress play the pivotal role in the induction of inflammation. Butyrate, l-Carnitine, and probiotics have the potential to control inflammation by reduction of main inflammatory cytokines, including NF-κB and TNF-α. They also stimulate antioxidant enzymes and inhibit IκB kinase (IKK). Regarding the beneficial effects of these three compounds in inflammation via several mechanisms, we hypothesize that the mixture of these compounds would be synergistically effective in reduction of inflammation and alleviation of IBD. Further experimental investigations are needed, to evaluate the hypothesis.
Affiliate Program     

Tango Jona
Tangokurs Rapperswil-Jona